These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
183 related articles for article (PubMed ID: 14523782)
21. Common adverse events associated with ribavirin therapy for Severe Fever with Thrombocytopenia Syndrome. Lu QB; Zhang SY; Cui N; Hu JG; Fan YD; Guo CT; Qin SL; Yang ZD; Wang LY; Wang HY; Zhang XA; Liu W; Cao WC Antiviral Res; 2015 Jul; 119():19-22. PubMed ID: 25892251 [TBL] [Abstract][Full Text] [Related]
22. Investigational use of ribavirin in the treatment of severe acute respiratory syndrome, Singapore, 2003. Leong HN; Ang B; Earnest A; Teoh C; Xu W; Leo YS Trop Med Int Health; 2004 Aug; 9(8):923-7. PubMed ID: 15303999 [TBL] [Abstract][Full Text] [Related]
23. Adequate timing of ribavirin reduction in patients with hemolysis during combination therapy of interferon and ribavirin for chronic hepatitis C. Arase Y; Ikeda K; Suzuki F; Suzuki Y; Saitoh S; Kobayashi M; Akuta N; Someya T; Hosaka T; Sezaki H; Kobayashi M; Kumada H J Gastroenterol; 2004 Nov; 39(11):1090-4. PubMed ID: 15580403 [TBL] [Abstract][Full Text] [Related]
24. Pregnancy outcome after exposure to injectable ribavirin during embryogenesis. Rezvani M; Koren G Reprod Toxicol; 2006 Jan; 21(1):113-5. PubMed ID: 16122903 [TBL] [Abstract][Full Text] [Related]
25. Serum hepatic enzyme manifestations in patients with severe acute respiratory syndrome: retrospective analysis. Cui HJ; Tong XL; Li P; Hao YX; Chen XG; Li AG; Zhang ZY; Duan J; Zhen M; Zhang B; Hua CJ; Gong YW World J Gastroenterol; 2004 Jun; 10(11):1652-5. PubMed ID: 15162543 [TBL] [Abstract][Full Text] [Related]
26. [Severe acute respiratory syndrome: the first transmissible disease of the 21st century]. Nicastri E; Petrosillo N; Macrì G; Ippolito G Recenti Prog Med; 2003; 94(7-8):295-303. PubMed ID: 12868234 [TBL] [Abstract][Full Text] [Related]
27. Temporal relationship of viral load, ribavirin, interleukin (IL)-6, IL-8, and clinical progression in patients with severe acute respiratory syndrome. Wang WK; Chen SY; Liu IJ; Kao CL; Chen HL; Chiang BL; Wang JT; Sheng WH; Hsueh PR; Yang CF; Yang PC; Chang SC; Clin Infect Dis; 2004 Oct; 39(7):1071-5. PubMed ID: 15472864 [TBL] [Abstract][Full Text] [Related]
28. Impact of ITPA gene polymorphisms on the risk of ribavirin-induced haemolytic anaemia using interferon-free antivirals for chronic hepatitis C. Esposito I; Benítez-Gutiérrez L; Treviño A; Arias A; Citores MJ; Requena S; Soriano V; Cuervas-Mons V; de Mendoza C Antivir Ther; 2017; 22(7):571-575. PubMed ID: 28198349 [TBL] [Abstract][Full Text] [Related]
29. Severe acute respiratory syndrome: Relapse? Hospital infection? Tsang OT; Chau TN; Choi KW; Tso EY; Lim W; Chiu MC; Tong WL; Lee PO; Lam BH; Ng TK; Lai JY; Yu WC; Lai ST Emerg Infect Dis; 2003 Sep; 9(9):1180-1. PubMed ID: 14531379 [No Abstract] [Full Text] [Related]
30. Prolonged disturbances of in vitro cytokine production in patients with severe acute respiratory syndrome (SARS) treated with ribavirin and steroids. Jones BM; Ma ES; Peiris JS; Wong PC; Ho JC; Lam B; Lai KN; Tsang KW Clin Exp Immunol; 2004 Mar; 135(3):467-73. PubMed ID: 15008980 [TBL] [Abstract][Full Text] [Related]
31. Ribavirin in the treatment of SARS: A new trick for an old drug? Koren G; King S; Knowles S; Phillips E CMAJ; 2003 May; 168(10):1289-92. PubMed ID: 12743076 [No Abstract] [Full Text] [Related]
32. High-dose pulse versus nonpulse corticosteroid regimens in severe acute respiratory syndrome. Ho JC; Ooi GC; Mok TY; Chan JW; Hung I; Lam B; Wong PC; Li PC; Ho PL; Lam WK; Ng CK; Ip MS; Lai KN; Chan-Yeung M; Tsang KW Am J Respir Crit Care Med; 2003 Dec; 168(12):1449-56. PubMed ID: 12947028 [TBL] [Abstract][Full Text] [Related]
33. How to avoid discontinuation of ribavirin in combination with interferon to maintain efficacy of treatment for chronic hepatitis C patients. Kasahara A J Gastroenterol; 2004 Nov; 39(11):1125-6. PubMed ID: 15580413 [No Abstract] [Full Text] [Related]
34. Autoimmune hemolytic anemia in HCV/HIV coinfected patients during treatment with pegylated alpha-2a interferon plus ribavirin. Vilar FC; Castro Gd; Moya MJ; Martinelli Ade L; De Santis GC; Cozac AP; Figueiredo JF Rev Soc Bras Med Trop; 2007; 40(6):678-80. PubMed ID: 18200424 [TBL] [Abstract][Full Text] [Related]
35. Role of nucleoside transporters SLC28A2/3 and SLC29A1/2 genetics in ribavirin therapy: protection against anemia in patients with chronic hepatitis C. Doehring A; Hofmann WP; Schlecker C; Zeuzem S; Sarrazin C; Berg T; Müller T; Herrmann E; Geisslinger G; Lötsch J Pharmacogenet Genomics; 2011 May; 21(5):289-96. PubMed ID: 21346688 [TBL] [Abstract][Full Text] [Related]